Doosan Fuel Cell (A336260) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
20 Feb, 2026Executive summary
Sales reached KRW 411.8 billion in 2024, up 58% year-over-year, surpassing initial targets in the CHPS general H2 market bidding with a 73% market share, and net borrowings decreased by KRW 22.8 billion.
Operating income was KRW -1.7 billion on a consolidated basis and KRW 0.3 billion on a separate basis, reflecting increased costs from facility investments.
Financial highlights
Sales grew 58% YoY to KRW 411.8 billion, driven by full reflection of CHPS project sales secured in 2023.
Cost of goods sold ratio increased from 84.8% to 91.2% due to lower CHPS project prices and higher fixed costs from investments.
Net income was KRW -10.5 billion, down from KRW -8.5 billion the previous year.
EBITDA for 2024 was KRW 16.4 billion, with a margin of 4.0% on a consolidated basis.
Outlook and guidance
Orders for 2025 are expected to rise significantly, with 127MW of CHPS projects won in 2024 to be reflected in 2025 orders.
Overseas expansion is anticipated, targeting pilot projects in China, Taiwan, and the US.
Funding needs in 2025 are expected to be lower as major facility investments conclude and working capital improves.
Latest events from Doosan Fuel Cell
- 2025 saw sales growth but deeper losses, with strong sales and order growth expected from 2026.A336260
Q4 202516 Mar 2026 - Sales surged 173% QoQ in 2Q24, with new H2 models and strong order growth fueling optimism.A336260
Q2 202420 Feb 2026 - 3Q24 revenue dropped 29.7% YoY, but strong CHPS orders and SOFC growth signal a rebound.A336260
Q3 202420 Feb 2026 - 1Q 2025 sales tripled YoY, but losses widened; growth initiatives and cost controls underway.A336260
Q1 202520 Feb 2026 - Q2 2025 sales jumped 48.5% YoY, with losses narrowing and robust order growth ahead.A336260
Q2 202520 Feb 2026 - Q3 2025 results show losses amid project delays, but robust order growth and SOFC ramp-up ahead.A336260
Q3 202520 Feb 2026